• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Endocrine therapy of metastatic breast cancer.

作者信息

PEARSON O H, WEST C D, LI M C, MACLEAN J P, TREVES N

出版信息

AMA Arch Intern Med. 1955 Feb;95(2):357-64. doi: 10.1001/archinte.1955.00250080179022.

DOI:10.1001/archinte.1955.00250080179022
PMID:13227660
Abstract
摘要

相似文献

1
Endocrine therapy of metastatic breast cancer.转移性乳腺癌的内分泌治疗
AMA Arch Intern Med. 1955 Feb;95(2):357-64. doi: 10.1001/archinte.1955.00250080179022.
2
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.芳香化酶抑制剂用于治疗绝经后妇女的晚期乳腺癌。
Cochrane Database Syst Rev. 2007 Jan 24(1):CD003370. doi: 10.1002/14651858.CD003370.pub2.
3
Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.绝经后转移性和早期乳腺癌女性内分泌治疗的进展
Oncologist. 2003;8(4):335-41. doi: 10.1634/theoncologist.8-4-335.
4
The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.Akt激活与转移性乳腺癌激素治疗耐药性之间的关联。
Eur J Cancer. 2006 Mar;42(5):629-35. doi: 10.1016/j.ejca.2005.11.025. Epub 2006 Feb 7.
5
Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience.500毫克氟维司群用于绝经后转移性乳腺癌患者：初步临床经验
Breast Cancer. 2016 Jul;23(4):617-23. doi: 10.1007/s12282-015-0612-0. Epub 2015 Apr 21.
6
p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer.p53蛋白积累预示着转移性乳腺癌对内分泌治疗的耐药性，并降低复发后的生存率。
Breast Cancer Res. 2006;8(4):R48. doi: 10.1186/bcr1536.
7
SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.SNAI2 上调与氟维司群耐药乳腺癌细胞的侵袭表型相关，是雌激素受体阳性转移性乳腺癌内分泌治疗反应不良的标志。
Breast Cancer Res. 2018 Jun 19;20(1):60. doi: 10.1186/s13058-018-0988-9.
8
Endocrine therapy for hormone treatment-naïve advanced breast cancer.针对未经激素治疗的晚期乳腺癌的内分泌治疗
Breast. 2016 Aug;28:161-6. doi: 10.1016/j.breast.2016.05.015. Epub 2016 Jun 18.
9
Systemic therapy of metastatic breast cancer.转移性乳腺癌的全身治疗
Acta Oncol. 1990;29(3):361-5. doi: 10.3109/02841869009090015.
10
Endocrine therapy in metastatic breast cancer.转移性乳腺癌的内分泌治疗
Cancer Treat Res. 1998;94:231-54. doi: 10.1007/978-1-4615-6189-7_13.

引用本文的文献

1
Insulin-like growth factor receptor inhibitors: baby or the bathwater?胰岛素样生长因子受体抑制剂：是弃之可惜，还是全盘否定？
J Natl Cancer Inst. 2012 Jul 3;104(13):975-81. doi: 10.1093/jnci/djs258.
2
[Change in the hypophysis after radiogold implantation].[放射性金植入后垂体的变化]
Dtsch Z Nervenheilkd. 1960;181:93-118.
3
The surgery of the endocrine system in carcinoma of the breast.乳腺癌内分泌系统手术
Postgrad Med J. 1958 Dec;34(398):628-31. doi: 10.1136/pgmj.34.398.628.
4
Surgical endocrine ablation for advanced breast cancer.晚期乳腺癌的手术内分泌消融治疗。
Postgrad Med J. 1957 Aug;33(382):372-82 passim. doi: 10.1136/pgmj.33.382.372.